The director of Africa’s Centers for Disease Control says the organization is talking to Pfizer about bringing its COVID-19 treatment pill to the continent, which has just passed 10 million cases
DAKAR, Senegal _ — The director of Africa’s Centers for Disease Control said the organization is talking to Pfizer about bringing its COVID-19 treatment pill to the continent, which has just passed 10 million cases.
The discussions come as Dr. John Nkengasong urges government and citizens not to relent on vaccinations and preventive measures as various countries come down from waves of increased infections from the omicron variant.
“We are working hand in hand. … We are in close discussions with Pfizer to see what can be done to make the drugs available on the continent,” Nkengasong said Thursday in a press briefing.
At least 39 countries have reported the new variant and the average increase of cases in Africa is about 11 percent, he said.
He noted that vaccination rates are still not high enough, saying governments are struggling because there are such high numbers of people only getting vaccinated when there is a peak, which leads to a lot of hospitalizations and pressure on the systems that can be avoided.
“My advice to the population on the continent is go get vaccinated,” he said. “If the population is not ready to go get the vaccines the governments have worked so hard to bring to the continent, I see why countries would not have an option other than to impose vaccine mandates.”
The continent has received more than 660 million doses of vaccines, with only about 340 million doses administered.
The strategy on countering COVID-19 in Africa is first vaccination, but “with the coming of new drugs, it appears it would be possible and recommended to treat even the mild cases,” WHO Africa regional emergency director Abdou Salam Gueye told reporters Thursday.
WHO added that “after a six-week surge, Africa’s fourth pandemic wave driven primarily by the omicron variant is flattening, marking the shortest-lived surge to date.” Deaths are lower than in the previous waves and hospitalizations remain low, WHO noted.
AP writer Cara Anna in Nairobi, Kenya, contributed.